Please enable JavaScript to continue using this application.

Compare $ABOS vs $NKTX | Chartloom

Compare

$ABOS vs $NKTX

Acumen Pharmaceuticals Inc · Nkarta Inc

ABOS

Acumen Pharmaceuticals Inc

NKTX

Nkarta Inc

Compare $ABOS vs $NKTX

Comparing Acumen Pharmaceuticals Inc and Nkarta Inc

ABOSAcumen Pharmaceuticals Inc

NKTXNkarta Inc

ABOSAcumen Pharmaceuticals Inc

Market cap

$155M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

5.9%

52W performance

13.8%

FCF yield

-59.4%

NKTXNkarta Inc

Market cap

$161M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

20.3%

52W performance

7.7%

FCF yield

-58.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ABOS

NKTX

Detailed metrics comparison

ABOS

Acumen Pharmaceuticals Inc

NKTX

Nkarta Inc

Market Cap

ABOS$155M

NKTX$161M

Enterprise Value

ABOS$127M

NKTX$136M

Price

ABOS$2.14

NKTX$2.25

P/E Ratio

ABOSN/A

NKTXN/A

P/S Ratio

ABOS102.45x

NKTX0.00x

EV/Sales

ABOS0.00x

NKTX0.00x

EV/EBITDA

ABOS0.00x

NKTX0.00x

P/B Ratio

ABOS2.58x

NKTX0.74x

P/FCF Ratio

ABOSN/A

NKTXN/A

EV/FCF

ABOS-1.38x

NKTX-1.45x

PEG Ratio

ABOSN/A

NKTXN/A

Forward P/E (NTM)

ABOSN/A

NKTXN/A

Forward P/S (NTM)

ABOSN/A

NKTXN/A

Revenue (TTM)

ABOS$0

NKTX$0

Revenue Growth (YoY)

ABOSN/A

NKTXN/A

Forward Rev Growth

ABOS1135.7%

NKTX2561.2%

Gross Margin (TTM)

ABOS0.0%

NKTX0.0%

Operating Margin (TTM)

ABOS0.0%

NKTX0.0%

EBITDA Margin (TTM)

ABOS0.0%

NKTX0.0%

Net Margin (TTM)

ABOS0.0%

NKTX0.0%

FCF Margin (TTM)

ABOSN/A

NKTXN/A

Net Income (TTM)

ABOS$-105M

NKTX$-117M

FCF (TTM)

ABOS$-92M

NKTX$-94M

EPS (TTM)

ABOS-$1.45

NKTX-$1.57

ROE (TTM)

ABOS-13627.0%

NKTX-3964.0%

ROA (TTM)

ABOS-8164.0%

NKTX-3045.0%

ROIC (TTM)

ABOS-9709.0%

NKTX-3964.0%

Cash

ABOS$59M

NKTX$25M

Debt

ABOS$32M

NKTX$0

Net Cash/Debt

ABOS$28M

NKTX$25M

Current Ratio (TTM)

ABOS2.47x

NKTX7.98x

Quick Ratio (TTM)

ABOS2.38x

NKTX7.76x

Debt/Equity (TTM)

ABOS0.55x

NKTX0.00x

Debt/Assets (TTM)

ABOS0.0%

NKTX0.0%

Interest Coverage (TTM)

ABOSN/A

NKTXN/A

Net Debt/EBITDA (TTM)

ABOS0.00x

NKTX0.00x

Beta

ABOS0.30

NKTX1.19

52W Performance

ABOS13.8%

NKTX7.7%

YTD Performance

ABOS5.9%

NKTX20.3%

% from 52W High

ABOS-40.6%

NKTX-39.5%

% from 52W Low

ABOS42.7%

NKTX32.4%

Asset Turnover (TTM)

ABOS0.00x

NKTX0.00x

FCF Yield (TTM)

ABOS-59.4%

NKTX-58.3%

Earnings Yield (TTM)

ABOS-68.0%

NKTX-72.9%

Dividend Yield (TTM)

ABOSN/A

NKTXN/A

Rule of 40

ABOS0.0

NKTX0.0

EV/GP/RG

ABOSN/A

NKTXN/A

Ticker research

View ABOS research View NKTX research

Metric	ABOS Acumen Pharmaceuticals Inc	NKTX Nkarta Inc
Market & Valuation
Market Cap	$155M	$161M
Enterprise Value	$127M	$136M
Price	$2.14	$2.25
P/E Ratio	N/A	N/A
P/S Ratio	102.45x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.58x	0.74x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.38x	-1.45x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	1135.7%	2561.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-105M	$-117M
FCF (TTM)	$-92M	$-94M
EPS (TTM)	-$1.45	-$1.57
ROE (TTM)	-13627.0%	-3964.0%
ROA (TTM)	-8164.0%	-3045.0%
ROIC (TTM)	-9709.0%	-3964.0%
Financial Health
Cash	$59M	$25M
Debt	$32M	$0
Net Cash/Debt	$28M	$25M
Current Ratio (TTM)	2.47x	7.98x
Quick Ratio (TTM)	2.38x	7.76x
Debt/Equity (TTM)	0.55x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.30	1.19
52W Performance	13.8%	7.7%
YTD Performance	5.9%	20.3%
% from 52W High	-40.6%	-39.5%
% from 52W Low	42.7%	32.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-59.4%	-58.3%
Earnings Yield (TTM)	-68.0%	-72.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ABOS research	View NKTX research

Valuation

P/S Ratio

NKTX

0.00x

ABOS

102.45x

EV/FCF

NKTX

-1.45x

ABOS

-1.38x

Growth & revenue

Forward Revenue Growth

NKTX

2561.2%

ABOS

1135.7%

Profitability & performance

Gross Margin

ABOS

0.0%

NKTX

0.0%

ROE

NKTX

-3964.0%

ABOS

-13627.0%

FCF Yield %

NKTX

-58.3%

ABOS

-59.4%

52-Week Performance

ABOS

13.8%

NKTX

7.7%

Detailed metrics comparison

ABOS

Acumen Pharmaceuticals Inc

NKTX

Nkarta Inc

Market Cap

ABOS$155M

NKTX$161M

Enterprise Value

ABOS$127M

NKTX$136M

Price

ABOS$2.14

NKTX$2.25

P/E Ratio

ABOSN/A

NKTXN/A

P/S Ratio

ABOS102.45x

NKTX0.00x

EV/Sales

ABOS0.00x

NKTX0.00x

EV/EBITDA

ABOS0.00x

NKTX0.00x

P/B Ratio

ABOS2.58x

NKTX0.74x

P/FCF Ratio

ABOSN/A

NKTXN/A

EV/FCF

ABOS-1.38x

NKTX-1.45x

PEG Ratio

ABOSN/A

NKTXN/A

Forward P/E (NTM)

ABOSN/A

NKTXN/A

Forward P/S (NTM)

ABOSN/A

NKTXN/A

Revenue (TTM)

ABOS$0

NKTX$0

Revenue Growth (YoY)

ABOSN/A

NKTXN/A

Forward Rev Growth

ABOS1135.7%

NKTX2561.2%

Gross Margin (TTM)

ABOS0.0%

NKTX0.0%

Operating Margin (TTM)

ABOS0.0%

NKTX0.0%

EBITDA Margin (TTM)

ABOS0.0%

NKTX0.0%

Net Margin (TTM)

ABOS0.0%

NKTX0.0%

FCF Margin (TTM)

ABOSN/A

NKTXN/A

Net Income (TTM)

ABOS$-105M

NKTX$-117M

FCF (TTM)

ABOS$-92M

NKTX$-94M

EPS (TTM)

ABOS-$1.45

NKTX-$1.57

ROE (TTM)

ABOS-13627.0%

NKTX-3964.0%

ROA (TTM)

ABOS-8164.0%

NKTX-3045.0%

ROIC (TTM)

ABOS-9709.0%

NKTX-3964.0%

Cash

ABOS$59M

NKTX$25M

Debt

ABOS$32M

NKTX$0

Net Cash/Debt

ABOS$28M

NKTX$25M

Current Ratio (TTM)

ABOS2.47x

NKTX7.98x

Quick Ratio (TTM)

ABOS2.38x

NKTX7.76x

Debt/Equity (TTM)

ABOS0.55x

NKTX0.00x

Debt/Assets (TTM)

ABOS0.0%

NKTX0.0%

Interest Coverage (TTM)

ABOSN/A

NKTXN/A

Net Debt/EBITDA (TTM)

ABOS0.00x

NKTX0.00x

Beta

ABOS0.30

NKTX1.19

52W Performance

ABOS13.8%

NKTX7.7%

YTD Performance

ABOS5.9%

NKTX20.3%

% from 52W High

ABOS-40.6%

NKTX-39.5%

% from 52W Low

ABOS42.7%

NKTX32.4%

Asset Turnover (TTM)

ABOS0.00x

NKTX0.00x

FCF Yield (TTM)

ABOS-59.4%

NKTX-58.3%

Earnings Yield (TTM)

ABOS-68.0%

NKTX-72.9%

Dividend Yield (TTM)

ABOSN/A

NKTXN/A

Rule of 40

ABOS0.0

NKTX0.0

EV/GP/RG

ABOSN/A

NKTXN/A

Ticker research

View ABOS research View NKTX research

Metric	ABOS Acumen Pharmaceuticals Inc	NKTX Nkarta Inc
Market & Valuation
Market Cap	$155M	$161M
Enterprise Value	$127M	$136M
Price	$2.14	$2.25
P/E Ratio	N/A	N/A
P/S Ratio	102.45x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.58x	0.74x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.38x	-1.45x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	1135.7%	2561.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-105M	$-117M
FCF (TTM)	$-92M	$-94M
EPS (TTM)	-$1.45	-$1.57
ROE (TTM)	-13627.0%	-3964.0%
ROA (TTM)	-8164.0%	-3045.0%
ROIC (TTM)	-9709.0%	-3964.0%
Financial Health
Cash	$59M	$25M
Debt	$32M	$0
Net Cash/Debt	$28M	$25M
Current Ratio (TTM)	2.47x	7.98x
Quick Ratio (TTM)	2.38x	7.76x
Debt/Equity (TTM)	0.55x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.30	1.19
52W Performance	13.8%	7.7%
YTD Performance	5.9%	20.3%
% from 52W High	-40.6%	-39.5%
% from 52W Low	42.7%	32.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-59.4%	-58.3%
Earnings Yield (TTM)	-68.0%	-72.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ABOS research	View NKTX research